Galapagos NV (GLPG)
28.62
-0.06
(-0.19%)
USD |
NASDAQ |
Apr 24, 16:00
28.62
0.00 (0.00%)
After-Hours: 20:00
Galapagos Market Cap : 1.886B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 161.87B |
| UCB SA | 53.31B |
| Celyad Oncology SA | 11.19M |
| Fagron NV | 1.943B |
| AgomAb Therapeutics NV | 540.49M |
Market Cap Related Metrics
| PE Ratio | 4.802 |
| PS Ratio | 1.468 |
| PEG Ratio | 0.0121 |
| Price to Book Value | 0.4963 |
| Price | 28.62 |
| Earnings Yield | 20.83% |
| PEGY Ratio | 0.0121 |
| Operating PE Ratio | 3.328 |
| Normalized PE Ratio | 3.256 |